Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Extended interval tarlatamab dosing shows consistent clinical activity in previously treated SCLC
Extended interval tarlatamab dosing shows consistent clinical activity in previously treated SCLC

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014

mCRPC: Challenges and opportunities in a booming area

Dr Nicolas Mottet - University Hospital, Saint-Étienne, France
mCRPC: Challenges and opportunities in a booming area ( Dr Nicolas Mottet - University Hospital, Saint-Étienne, France )
10 Jan 2014

Understanding the biology of the disease to guide treatment choices

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland
Understanding the biology of the disease to guide treatment choices ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Ireland )
10 Jan 2014

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands
Predictors of response to mCRPC therapy: where do we stand? ( Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands )
10 Jan 2014

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK
Managing mCRPC in daily practice: a pragmatic approach ( Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK )
10 Jan 2014

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )
10 Jan 2014

The Personalized Medicine project: Biobanking solutions

Dr Gabriele Weiler - Fraunhofer IBMT, Germany
The Personalized Medicine project: Biobanking solutions ( Dr Gabriele Weiler - Fraunhofer IBMT, Germany )
6 Jan 2014

The Personalized Medicine project: Developing the clinical trial management tool

Prof Norbert Graf - Saarland University, Germany
The Personalized Medicine project: Developing the clinical trial management tool ( Prof Norbert Graf - Saarland University, Germany )
6 Jan 2014

The Personalized Medicine project: The ObTiMA tool

Dr Simona Rossi - Swiss Institute of Bioinformatics, Switzerland
The Personalized Medicine project: The ObTiMA tool ( Dr Simona Rossi - Swiss Institute of Bioinformatics, Switzerland )
6 Jan 2014

The Personalized Medicine project: The ALGA Questionnaire

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
The Personalized Medicine project: The ALGA Questionnaire ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
6 Jan 2014

The Personalized Medicine project: Developing software for clinical trials

Holger Stenzhorn - Saarland University Hospital, Germany
The Personalized Medicine project: Developing software for clinical trials ( Holger Stenzhorn - Saarland University Hospital, Germany )
6 Jan 2014

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA
Trial results at ASH 2013 ( Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA )
1 Jan 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation